Reply To: Drawing Labs from a Central Line

  • Janet DeJean

    January 26, 2016 at 6:42 pm

    In our office visit area the primary role of the LVN is to access ports, draw labs, and perform dressing changes on central lines.  In the Infusion Area the RN’s perform all of those tasks if the patient isn’t already accessed from their office visit.  We do not allow MA’s or phlebotomist to touch the central lines.


    Janet DeJean, MSN, RN, CPON

    Outpatient Education Coordinator

    Texas Children’s Cancer & Hematology Centers

    Texas Childrens Hospital

    6701 Fannin Street |Suite 1410| Houston, Tx  77030 

    (: 832-822-4870 | Ê: 832-825-4557

    Pager: 832-824-2099 # 1010 | *






    The information in this e-mail may be confidential and/or
    privileged. If you are not the intended recipient or an
    authorized representative of the intended recipient, you
    are hereby notified that any review, dissemination, or
    copying of this e-mail and its attachments, if any, or
    the information contained herein is prohibited. If you
    have received this e-mail in error, please immediately
    notify the sender by return e-mail and delete this e-mail
    from your computer system. Thank you.

    ——Original Message——

    Hello All,


    I have a question about who, in your respective institutions, is allowed to draw labs from the Central Lines of the Heme/Onc and Stem Cell patient population.  Does your support staff draw from a central line with proper training (phlebotomists, MAs or LVNs?) or  is your policy similar to ours to where only the RN can draw from the Central Lines of Pediatric Patients?


    Thank you so much for your help and responses!



    Maritza Salazar-Abshire, MSN, MEd, RN, CPON

    Senior Nursing Instructor

    Department of Nursing Education

    The University of Texas MD Anderson Cancer Center

    1515 Holcombe Boulevard,  Box 82, Y5.5628

    Houston, TX 77030-4009

    O:  713-745-0383

    F:  713-792-7332

    P:  713-404-8715




    The information contained in this e-mail message may be privileged, confidential, and/or protected from disclosure. This e-mail message may contain protected health information (PHI); dissemination of PHI should comply with applicable federal and state laws. If you are not the intended recipient, or an authorized representative of the intended recipient, any further review, disclosure, use, dissemination, distribution, or copying of this message or any attachment (or the information contained therein) is strictly prohibited. If you think that you have received this e-mail message in error, please notify the sender by return e-mail and delete all references to it and its contents from your systems.